indice consenso chileno de manejo de fármacos antiepilépticos en ...

1998; 339:792–8– Trinka E. The use of valproate and new antiepilepticdrugs in status epilepticus. Epilepsia 2007;48(Suppl.8):49-51– Tsao CY. Current trends in the treatment of infantilespasms. Neuropsychiatric Dis Treat 2009;5:289–299– Tsuru T, Mori M, Mizuguchi M, et al: Effects of highdoseintravenous corticosteroid therapy in Landau-Kleffner syndrome. Pediatr Neurol 22:145-147, 2000– Tzitiridou M, Panou T, Ramantani G, et al.Oxcarbazepine monotherapy in benign childhoodepilepsy with centrotemporal spikes: a clinical andcognitive evaluation. Epilepsy Behav 2005;7(3):458-67– Vajda FJ, O’Brien TJ, Hitchcock A, Graham J, CookM, Lander C, Eadie MJ. Critical relationship betweensodium valproate dose and human teratogenicity:results of the Australian register of anti-epileptic drugsin pregnancy. J Clin Neurosci 2004; 11:854–858.– Van Rijckevorsel K. Treatment of Lennox-Gastaut syndrome: overview and recent findings.Neuropsychiatric Dis Treat 2008:4(6) 1001-19– Verrotti A, Coppola G, Manco R, et al. Levetiracetammonotherapy for children and adolescents with benignrolandic seizures. Seizure 2007; 16(3):271-5– Verrotti A, Manco R, Marco G, Chiarelli F, FranzoniE. The treatment of juvenile myoclonic epilepsy. ExpertRev Neurother 2006; 6:847-854– Verrotti A, Parisi P, Loiacono G, Mohn A, et al.Levetiracetam monotherapy for childhood occipitalepilepsy of Gastaut. Acta Neurol Scand 2009, 120(5): 342-346– Villarreal HJ, Wilder BJ, Willmore LJ. et al. Effect ofvalproic acid on spike and wave discharges in patientswith absence seizures. Neurology 1978; 28:886-891– Vining EP. Ethosuximide in childhood absenceepilepsy-older and better. N Engl J Med. 2010,4;362(9):843-5– Walker M, Cross H, Smith S, Young C et al.Nonconvulsive status epilepticus: Epilepsy ResearchFoundation workshop reports. Epileptic Disord. 2005Sep;7(3):253-96.– Wheless JW, Clarke DF, Arzimanoglou A et Al.Treatment of pediatric epilepsy: European expertopinion, Epileptic Disord 2007. 9, (4) 353-412– Wheless JW, Conry J, Krauss G, Mann A, LoPrestiA, Narurkar M. Safety and tolerability of rufinamide inchildren with epilepsy: a pooled analysis of 7 clinicalstudies. J. Child Neurol 2009; 24: 1520-5– Wilfong A, Schultz R. Zonisamide for absenceseizures. Epilepsy Res 2005;64:31–4.– Wirrell E, Sherman EM, Vanmastright R, HamiwkaL. Deterioration in cognitive function in children withbenign epilepsy of childhood with central temporalspikes treated with sulthiame. J Child Neurol 2008;23:14–21– Yanagaki S, Oguni H, Hayashi K, et al. A comparativestudy of high dose and low-dose ACTH therapy for Westsyndrome. Brain Dev 1999; 21:461–467– Yoong M, Chin R F M and Scott R C. Management ofconvulsive status epilepticus in children. Arch Dis ChildEduc Pract Ed 2009; 94: 1-925